Immix Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $18.2M
Liabilities Breakdown FY2021
Total Liabilities: $202.0K
Asset Breakdown
Total Assets: $18.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.6M | 97.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.7K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $541.9K | 3.0% |
Liabilities Breakdown
Total Liabilities: $202.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $142.9K | 70.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $59.1K | 29.3% |